Patents by Inventor Stephane Le Bihan

Stephane Le Bihan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030027259
    Abstract: The invention provides isolated nucleic acid molecules, designated ABCG4 transporter nucleic acid molecules, which encode novel ABC transporter family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing ABCG4 transporter nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which an ABCG4 transporter gene has been introduced or disrupted. The invention further provides isolated ABCG4 transporter proteins, fusion proteins, antigenic peptides, anti-ABCG4 transporter antibodies, and screening assays for ABCG4 transporter modulators. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: March 1, 2002
    Publication date: February 6, 2003
    Applicant: Active Pass Pharmaceuticals, Inc.
    Inventors: Hongyun Chen, Stephane Le Bihan
  • Publication number: 20020173004
    Abstract: The invention provides isolated nucleic acid molecules, designated ABCA6 transporter nucleic acid molecules, which encode novel ABC transporter family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing ABCA6 transporter nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which an ABCA6 transporter gene has been introduced or disrupted. The invention further provides isolated ABCA6 transporter proteins, fusion proteins, antigenic peptides, anti-ABCA6 transporter antibodies, and screening assays for ABCA6 transporter modulators. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: March 4, 2002
    Publication date: November 21, 2002
    Applicant: Active Pass Pharmaceuticals, Inc.
    Inventors: Hongyun Chen, Stephane Le Bihan, Barbara Kulhanek
  • Publication number: 20020123107
    Abstract: The invention provides isolated nucleic acid molecules, designated ABCA5 transporter nucleic acid molecules, which encode novel ABC transporter family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing ABCA5 transporter nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which an ABCA5 transporter gene has been introduced or disrupted. The invention further provides isolated ABCA5 transporter proteins, fusion proteins, antigenic peptides, anti-ABCA5 transporter antibodies, and screening assays for ABCA5 transporter modulators. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: March 1, 2002
    Publication date: September 5, 2002
    Applicant: Active Pass Pharmaceuticals, Inc.
    Inventors: Hongyun Chen, Ligia Kilinski, Stephane Le Bihan
  • Publication number: 20020123106
    Abstract: The invention provides isolated nucleic acid molecules, designated ABCA9 transporter nucleic acid molecules, which encode novel ABC transporter family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing ABCA9 transporter nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which an ABCA9 transporter gene has been introduced or disrupted. The invention further provides isolated ABCA9 transporter proteins, fusion proteins, antigenic peptides, anti-ABCA9 transporter antibodies, and screening assays for ABCA9 transporter modulators. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
    Type: Application
    Filed: March 4, 2002
    Publication date: September 5, 2002
    Applicant: Active Pass Pharmaceuticals, Inc.
    Inventors: Hongyun Chen, Stephane Le Bihan, Parimal S. Nathwani, Bruce P. Connop